EROXON Trademark

Trademark Overview

On Friday, September 23, 2016, a trademark application was filed for EROXON with the United States Patent and Trademark Office. The USPTO has given the EROXON trademark a serial number of 87181787. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Friday, November 14, 2025. This trademark is owned by Futura Medical Developments Ltd. The EROXON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products in the form of gels and creams for the treatment of sexual dysfunction
eroxon

General Information

Serial Number87181787
Word MarkEROXON
Filing DateFriday, September 23, 2016
Status701 - SECTION 8 - ACCEPTED
Status DateFriday, November 14, 2025
Registration Number5410070
Registration DateTuesday, February 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2017

Trademark Statements

Goods and ServicesPharmaceutical products in the form of gels and creams for the treatment of sexual dysfunction

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 28, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFutura Medical Developments Ltd
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGuildford, Surrey GU27YG
GB
Party NameFutura Medical Developments Ltd
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGuildford, Surrey GU27YG
GB
Party NameFutura Medical Developments Ltd
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGuildford, Surrey GU27YG
GB

Trademark Events

Event DateEvent Description
Tuesday, September 27, 2016NEW APPLICATION ENTERED
Wednesday, September 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 29, 2016ASSIGNED TO EXAMINER
Monday, January 9, 2017NON-FINAL ACTION WRITTEN
Monday, January 9, 2017NON-FINAL ACTION E-MAILED
Monday, January 9, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 13, 2017NON-FINAL ACTION WRITTEN
Monday, March 13, 2017NON-FINAL ACTION E-MAILED
Monday, March 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 28, 2017TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, January 17, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 28, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, January 24, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 9, 2024TEAS SECTION 8 RECEIVED
Monday, March 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 22, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 22, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 22, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, August 22, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, August 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 31, 2025POST REGISTRATION ACTION MAILED - SEC. 8
Sunday, April 27, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, November 14, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, November 14, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

eroxon treatment sexual dysfunction creams gels products form pharmaceutical